Results 111 to 120 of about 18,251 (231)

Improved dosage form of the combined alendronate and calcitriol (Maxmarvil®) on the absorption of alendronate in Korean postmenopausal women.

, 2013
Alendronate is one of the most potent anti-osteoporotic agents for postmenopausal osteoporosis. However, high doses of alendronate cause esophageal irritation, myalgia, gastrointestinal discomfort and decrease of serum calcium level. Recently, Maxmarvil®
Chung, YS, Choi, YJ, Kim, SH
core   +1 more source

Efficacy and Safety of Generic Alendronate for Osteoporosis Treatment

Atthakorn Jarusriwanna,1,* Saran Malisorn,1,* Sirikarn Tananoo,1 Kwanchanok Areewong,2 Supachok Rasamimongkol,1 Artit Laoruengthana1 1Department of Orthopaedics, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand; 2Department of ...
Areewong K, Jarusriwanna A, Malisorn S, Tananoo S, Rasamimongkol S, Laoruengthana A   +5 more
core  

Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture

, 2011
Jun Iwamoto1, Yoshihiro Sato2, Mitsuyoshi Uzawa3, Tsuyoshi Takeda1, Hideo Matsumoto11Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Department of Neurology, Mitate Hospital, Fukuoka, Japan; 3Department of ...
Iwamoto J, Matsumoto H, Takeda T, Uzawa M, Sato Y   +4 more
core  

Octreotide ameliorates alendronate-induced gastric injury

, 2004
Alendronate causes serious gastrointestinal adverse effects. The aim of this study was to investigate whether octreotide, a synthetic somatostatin analogue, improves the alendronate-induced gastric injury.
ELÇİOĞLU, HATİCE KÜBRA, ŞENER, GÖKSEL   +1 more
core   +1 more source

Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures

, 2009
Jun Iwamoto1, Atsushi Miyata2, Yoshihiro Sato3, Tsuyoshi Takeda1, Hideo Matsumoto11Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Department of Internal Medicine, Yahata Clinic, Tokyo, Japan; 3Department of ...
Atsushi Miyata, Jun Iwamoto, et al, Yoshihiro Sato   +3 more
core  

The Effect of Alendronate and Calcitonin Treatments on Bone Mineral Density and Quality of Life in Women With Postmenopausal Osteoporosis

, 2002
The aim of this study was to compare the effect of alendronate and calcitonin treatments on bone mineral density (BMD) and quality of life of women with postmenopausal osteoporosis.
İ. Dalkıran, F. Taşçıoğlu, C. Öner, E. Sırmagül, O. Armağan   +4 more
core  

ALENDRONATE-INDUCED RESPIRATORY DISTRESS

, 2020
Respiratory distress is a rare adverse effect of alendronate that is typically associated with severe dyspnoea and wheezing and typically requires hospitalization.
M, PRAVALIKA, V, SRIVANI, PAMU, SAGAR
core  

Radiodensitometric and DXA analyses for the measurement of bone mineral density after systemic alendronate therapy

Brazilian Oral Research, 2013
Precise techniques for the measurement of maxillary bone mineral density (BMD) are useful for the early diagnosis of systemic diseases. The aim of this study was to compare in vivo the efficacy of dual-energy x-ray absorptiometry (DXA) and radiographic ...
Marília Pacífico Lucisano, Paulo Nelson-Filho, Leslie Morse, Ricardo Battaglino, Plauto Christopher Aranha Watanabe, Raquel Assed Bezerra da Silva, Lea Assed Bezerra da Silva   +6 more
doaj  

Alendronate treatment rescues the effects of compressive loading of TMJ in osteogenesis imperfecta mice

Progress in Orthodontics
Background Osteogenesis imperfecta (OI) is a genetic disorder of connective tissue caused by mutations associated with type I collagen, which results in defective extracellular matrix in temporomandibular joint (TMJ) cartilage and subchondral bone.
Po-Jung Chen, Shivam Mehta, Eliane H. Dutra, Sumit Yadav   +3 more
doaj   +1 more source

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis

, 2010
Jun Iwamoto1, Yoshihiro Sato2, Mitsuyoshi Uzawa3, Tsuyoshi Takeda1, Hideo Matsumoto11Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Department of Neurology, Mitate Hospital, Fukuoka, Japan; 3Department of ...
Jun Iwamoto, Mitsuyoshi Uzawa, et al, Yoshihiro Sato   +3 more
core